<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: new drugs</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Webcam technology used to measure medications' effects on the heart</title>
   	 <description>A common component in webcams may help drug makers and prescribers address a common side-effect of drugs called cardiotoxicity, an unhealthy change in the way the heart beats. Researchers at Brigham and Women's Hospital (BWH) have used the basic webcam technology to create a tool to look at the effects of medications in real time on heart cells, called cardiomyocytes. These findings were published in the journal, Lab on a Chip on April 11, 2011.</description>
     <link>http://phys.org/news223650574.html</link>
	 <category>Chemistry</category>
	 <pubDate>Tue, 03 May 2011 14:09:57 EST</pubDate>
	 <guid isPermaLink="false">news223650574</guid>
	 
</item>
<item>
     <title>FDA panel endorses Vertex hepatitis C drug</title>
   	 <description>(AP) --  Federal health experts say an experimental hepatitis C drug from Vertex Pharmaceuticals Inc. is a significant step forward in treating the virus, despite a high rate of rashes among patients taking the tablet.</description>
     <link>http://phys.org/news223223987.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 28 Apr 2011 15:40:18 EST</pubDate>
	 <guid isPermaLink="false">news223223987</guid>
	 
</item>
<item>
     <title>FDA says Vertex hepatitis drug is highly effective</title>
   	 <description>(AP) --  Federal health officials say a highly anticipated hepatitis C drug from Vertex Pharmaceuticals successfully treats a clear majority of patients in less time than older medicines that have been used for 20 years.</description>
     <link>http://phys.org/news223035623.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 26 Apr 2011 11:40:06 EST</pubDate>
	 <guid isPermaLink="false">news223035623</guid>
	 
</item>
<item>
     <title>Molecular architecture of key NMDA receptor subunit revealed</title>
   	 <description>Structural biologists at Cold Spring Harbor Laboratory (CSHL) in collaboration with colleagues at Emory University have determined the molecular structure of a key portion, or subunit, of a receptor type commonly expressed in brain cells.  The receptor is one of several NMDA (N-methyl-D-aspartate) receptor variants, and the subunit in question is that which specifically binds with excitatory neurotransmitters, most notably glutamate, the brain's most prevalent excitatory neurotransmitter.</description>
     <link>http://phys.org/news223035557.html</link>
	 <category>Chemistry</category>
	 <pubDate>Tue, 26 Apr 2011 11:19:48 EST</pubDate>
	 <guid isPermaLink="false">news223035557</guid>
	 
</item>
<item>
     <title>Toward new medications for chronic brain diseases</title>
   	 <description>A needle-in-the-haystack search through nearly 390,000 chemical compounds had led scientists to a substance that can sneak through the protective barrier surrounding the brain with effects promising for new drugs for Parkinson's and Huntington's disease. They report on the substance, which blocks formation of cholesterol in the brain, in the journal, ACS Chemical Biology.</description>
     <link>http://phys.org/news222513356.html</link>
	 <category>Chemistry</category>
	 <pubDate>Wed, 20 Apr 2011 10:16:29 EST</pubDate>
	 <guid isPermaLink="false">news222513356</guid>
	 
</item>
<item>
     <title>Nanopolymer shows promise for helping reduce cancer side effects</title>
   	 <description>(PhysOrg.com) -- A Purdue University biochemist has demonstrated a process using nanotechnology to better assess whether cancer drugs hit their targets, which may help reduce drug side effects.</description>
     <link>http://phys.org/news221206834.html</link>
	 <category>Nanotechnology</category>
	 <pubDate>Tue, 05 Apr 2011 07:50:02 EST</pubDate>
	 <guid isPermaLink="false">news221206834</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/nanopolymers.jpg" width="90" height="90" />
</item>
<item>
     <title>Data suggest liver experts should take care when prescribing novel antiviral HCV drugs</title>
   	 <description>Data presented at the International Liver Congress highlight the fact that new novel antiviral compounds for the treatment of hepatitis C virus (HCV) must be prescribed and monitored by experts and specialists to ensure resistance is minimised.1,2,3,4,5,6</description>
     <link>http://phys.org/news220938368.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 02 Apr 2011 04:46:51 EST</pubDate>
	 <guid isPermaLink="false">news220938368</guid>
	 
</item>
<item>
     <title>Placing value, price on new drugs: The challenge facing new UK policy, say Hopkins bioethicists</title>
   	 <description>The United States should pay close attention to how the United Kingdom carries out plans to assess a new drug's worth using factors that go beyond clinical and cost effectiveness, according to researchers at the Johns Hopkins Berman Institute of Bioethics.</description>
     <link>http://phys.org/news220873615.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 01 Apr 2011 10:47:37 EST</pubDate>
	 <guid isPermaLink="false">news220873615</guid>
	 
</item>
<item>
     <title>Intelligent design: Engineered protein fragment blocks the AIDS virus from entering cells</title>
   	 <description>In what could be a potential breakthrough in the battle against AIDS and a major development in the rational design of new drugs, scientists have engineered a new protein that prevents the virus from entering cells. This protein is based on a naturally occurring protein in the body that protects cells from viruses, except the man-made version does not cause inflammation and other side effects at the dosages needed to inhibit AIDS. This discovery was published in the April 2011 issue of The FASEB Journal.</description>
     <link>http://phys.org/news220798587.html</link>
	 <category>Biology</category>
	 <pubDate>Thu, 31 Mar 2011 13:57:26 EST</pubDate>
	 <guid isPermaLink="false">news220798587</guid>
	 
</item>
<item>
     <title>Potential new medicines show promise for treating colon cancer, asthma</title>
   	 <description>In what they described as the opening of a new era in the development of potentially life-saving new drugs, scientists today reported discovery of a way to tone down an overactive gene involved in colon cancer and block a key protein involved in asthma attacks. Those targets long had ranked among hundreds of thousands that many scientists considered to be &quot;undruggable,&quot; meaning that efforts to reach them with conventional medicines were doomed to fail.</description>
     <link>http://phys.org/news220548852.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 28 Mar 2011 16:34:32 EST</pubDate>
	 <guid isPermaLink="false">news220548852</guid>
	 
</item>
<item>
     <title>The gene processes that drive acute myeloid leukaemia</title>
   	 <description>Researchers have described how the most common gene mutation found in acute myeloid leukaemia starts the process of cancer development and how it can cooperate with a well-defined group of other mutations to cause full-blown leukaemia.</description>
     <link>http://phys.org/news220449667.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 27 Mar 2011 13:02:02 EST</pubDate>
	 <guid isPermaLink="false">news220449667</guid>
	 
</item>
<item>
     <title>Snake venoms have not revealed all their secrets</title>
   	 <description>For several decades, snake venoms have been used in pharmacology to make new drugs. But a French team of pharmacologists, clinicians, systematists and conservation biologists, headed by Nicolas Vidal of the Laboratory &amp;#147;Syst&amp;#233;matique, Adaptation, Evolution,&quot; have shown that such venoms are largely under-exploited. They decided to pool their efforts to make full use of these resources in pharmaceutical compounds and to safeguard threatened species. The results of this study are published this week in the journal Bioessays.</description>
     <link>http://phys.org/news220098497.html</link>
	 <category>Biology</category>
	 <pubDate>Wed, 23 Mar 2011 11:37:33 EST</pubDate>
	 <guid isPermaLink="false">news220098497</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/snakevenomsh.jpg" width="90" height="90" />
</item>
<item>
     <title>Natural compounds: the future of anti-malarial treatment</title>
   	 <description>In the run up to World Malaria Day on the 25th April 2011, BioMed Central's open access journal Malaria Journal takes a long hard look at the development of natural compounds for use in the fight against malaria.</description>
     <link>http://phys.org/news219350003.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 14 Mar 2011 19:33:35 EST</pubDate>
	 <guid isPermaLink="false">news219350003</guid>
	 
</item>
<item>
     <title>HP speeds drug discovery research with inkjet technology</title>
   	 <description>HP today announced an innovative drug research application for its inkjet technology that enables pharmaceutical companies to more efficiently develop better drugs through vastly more precise dispensing of dosages.</description>
     <link>http://phys.org/news219070691.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 11 Mar 2011 12:58:25 EST</pubDate>
	 <guid isPermaLink="false">news219070691</guid>
	 
</item>
<item>
     <title>New instrument for analyzing viruses</title>
   	 <description>Scientists in Israel and California have developed an instrument for rapidly analyzing molecular interactions that take place viruses and the cells they infect. By helping to identify interactions between proteins made by viruses like HIV and hepatitis and proteins made by the human cells these viruses infect, the device may help scientists develop new ways of disrupting these interactions and find new drugs for treating those infections.</description>
     <link>http://phys.org/news218826855.html</link>
	 <category>Chemistry</category>
	 <pubDate>Tue, 08 Mar 2011 17:40:03 EST</pubDate>
	 <guid isPermaLink="false">news218826855</guid>
	 
</item>
<item>
     <title>HIV patients out of drugs, harassed in Ukraine</title>
   	 <description>(AP) --  AIDS drugs turned Andrei from a sickly baby into an energetic toddler, who giggles as he goes sledding in his snow-covered backyard. But the health of the 2-year-old is again at risk - he is out of his medication.</description>
     <link>http://phys.org/news216997192.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 15 Feb 2011 13:00:21 EST</pubDate>
	 <guid isPermaLink="false">news216997192</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/hivpatientso.jpg" width="90" height="90" />
</item>
<item>
     <title>China and Taiwan sign drug development pact</title>
   	 <description>(AP) --  Senior envoys from China and Taiwan signed an agreement Tuesday to cooperate in the development of new drugs, as the two economies continue to move closer.</description>
     <link>http://phys.org/news212127142.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 21 Dec 2010 04:13:08 EST</pubDate>
	 <guid isPermaLink="false">news212127142</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/chinaandtaiw.jpg" width="90" height="90" />
</item>
<item>
     <title>I-SPY 2 study speeds up treatment for breast cancer</title>
   	 <description>A clinical trial that aims to speed up the study of new treatments for certain subtypes of breast cancer now has a designated study site at the Diane O'Connor Thompson Breast Center at the University of Colorado Hospital.</description>
     <link>http://phys.org/news209398985.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 19 Nov 2010 14:23:15 EST</pubDate>
	 <guid isPermaLink="false">news209398985</guid>
	 
</item>
<item>
     <title>Experimental blood thinner gets high marks</title>
   	 <description>An experimental blood thinner called rivaroxaban is at least as good at preventing strokes as the old &quot;war horse&quot; warfarin, which has been used for decades in people with erratic heartbeats, researchers said Monday. The drug also sharply reduces the risk of major bleeding that is seen with warfarin.</description>
     <link>http://phys.org/news209232621.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 17 Nov 2010 17:40:01 EST</pubDate>
	 <guid isPermaLink="false">news209232621</guid>
	 
</item>
<item>
     <title>UNC team discovers promising target for new pancreatic cancer treatments</title>
   	 <description>One of the most frustrating problems faced by doctors who treat pancreatic cancer is the lack of effective therapeutic options.  More than 38,000 people in the United States die of the disease each year, and new drugs and treatments are desperately needed.</description>
     <link>http://phys.org/news208172986.html</link>
	 <category>Chemistry</category>
	 <pubDate>Fri, 05 Nov 2010 11:00:01 EST</pubDate>
	 <guid isPermaLink="false">news208172986</guid>
	 
</item>
<item>
     <title>Obsessing over strep throat in kids</title>
   	 <description>A common infection in children, strep throat can lead to problems with a child's heart, joints or brain if left untreated. And when the brain is involved, motor and mental functioning may be compromised, leading to syndromes such as attention deficit disorder and obsessive-compulsive disorder (OCD).</description>
     <link>http://phys.org/news206799444.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 20 Oct 2010 13:17:39 EST</pubDate>
	 <guid isPermaLink="false">news206799444</guid>
	 
</item>
<item>
     <title>Tuberculosis protects itself against toxic agents sent to destroy it</title>
   	 <description>(PhysOrg.com) -- Tuberculosis fights off the toxic agents, acidity and oxidants, that our immune system sends to destroy it, which is why the maddeningly drug-resistant bacterium can survive in harsh conditions in our bodies for essentially as long as its human host lives, new research shows.</description>
     <link>http://phys.org/news206111014.html</link>
	 <category>Biology</category>
	 <pubDate>Tue, 12 Oct 2010 14:03:58 EST</pubDate>
	 <guid isPermaLink="false">news206111014</guid>
	 
</item>
<item>
     <title>Scientists discover how dengue virus infects cells</title>
   	 <description>(PhysOrg.com) -- National Institutes of Health researchers have discovered a key step in how the dengue virus infects a cell. The discovery one day may lead to new drugs to prevent or treat the infection.</description>
     <link>http://phys.org/news206110646.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 12 Oct 2010 13:58:05 EST</pubDate>
	 <guid isPermaLink="false">news206110646</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/5-scientistsdi.jpg" width="90" height="91" />
</item>
<item>
     <title>Translating Chinese medicine for the West</title>
   	 <description>In a traditional Chinese medicine store in central Beijing, part of the Tongrentang chain founded 342 years ago, three white-coated workers follow traditions that stretch even further back in time. They sort and chop an exotic variety of herbs and roots for customers to take home and boil up.</description>
     <link>http://phys.org/news206011808.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 11 Oct 2010 13:30:01 EST</pubDate>
	 <guid isPermaLink="false">news206011808</guid>
	 
</item>
<item>
     <title>Abbott withdraws diet pill in US, Canada</title>
   	 <description>(AP) --  Abbott Laboratories said Friday it will withdraw its diet pill Meridia in the U.S. and Canada, almost a year after studies showed the drug increases the risk of heart attack and stroke in patients with a history of heart disease.</description>
     <link>http://phys.org/news205763696.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 08 Oct 2010 13:35:30 EST</pubDate>
	 <guid isPermaLink="false">news205763696</guid>
	 
</item>
<item>
     <title>It's time to phase out codeine</title>
   	 <description>It is time to phase out the use of codeine as a pain reliever because of its significant risks and ineffectiveness as an analgesic, states an editorial in CMAJ (Canadian Medical Association Journal).</description>
     <link>http://phys.org/news205414277.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 04 Oct 2010 12:50:09 EST</pubDate>
	 <guid isPermaLink="false">news205414277</guid>
	 
</item>
<item>
     <title>Best drug development results from computer/test tube combination</title>
   	 <description>While computer simulations of how the body metabolises drugs save both time and money, the best results when developing new drugs come from combining such simulations with laboratory experiments, reveals a researcher from the University of Gothenburg.</description>
     <link>http://phys.org/news205403615.html</link>
	 <category>Chemistry</category>
	 <pubDate>Mon, 04 Oct 2010 09:33:57 EST</pubDate>
	 <guid isPermaLink="false">news205403615</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/1-bestdrugdeve.jpg" width="90" height="90" />
</item>
<item>
     <title>Drugs for low libido raise concerns over industry 'construction' of new diseases</title>
   	 <description>Drug companies have not only sponsored the science of a new condition known as female sexual dysfunction, they have helped to construct it, in order to build global markets for new drugs, reveals an article in this week's British Medical Journal.</description>
     <link>http://phys.org/news205093800.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Sep 2010 19:30:19 EST</pubDate>
	 <guid isPermaLink="false">news205093800</guid>
	 
</item>
<item>
     <title>Pharmaceutical conservation key to slowing rise of antibiotic-resistant infections</title>
   	 <description>The United States must focus on conserving the use of antibacterial drugs, or face a public health crisis from rapidly rising rates of antibiotic-resistant infections, according to an analysis out today.</description>
     <link>http://phys.org/news203053450.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 07 Sep 2010 05:30:02 EST</pubDate>
	 <guid isPermaLink="false">news203053450</guid>
	 
</item>
<item>
     <title>Researchers cut years from drug development with nanoscopic bead technology</title>
   	 <description>New research accepted by the Journal of Molecular Recognition confirms that a revolutionary technology developed at Wake Forest University will slash years off the time it takes to develop drugs - bringing vital new treatments to patients much more quickly.</description>
     <link>http://phys.org/news198426204.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 15 Jul 2010 15:50:03 EST</pubDate>
	 <guid isPermaLink="false">news198426204</guid>
	 
</item>


</channel>
</rss>
